Evidence map›Paper›PMID 29509900›Full record

ArticleHuman molecular genetics2018

A genetic modifier suggests that endurance exercise exacerbates Huntington's disease.

Silvia Corrochano, Gonzalo Blanco, Debbie Williams, Jessica Wettstein, Michelle Simon, Saumya Kumar, Lee Moir, Thomas Agnew, Michelle Stewart, Allison Landman and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington's Disease.Journal of functional morphology and kinesiology · 2022
    Review
  5. Article
  6. Review
  7. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.International journal of molecular sciences · 2021
    Review
  8. Article
  9. New Synthetic 3-Benzoyl-5-Hydroxy-2Oxidative medicine and cellular longevity · 2020
    Article
  10. Review
  11. Uses for humanised mouse models in precision medicine for neurodegenerative disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2019
    Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Silvia CorrochanoMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Gonzalo BlancoDepartment of Biology, University of York, York, UK.
Debbie WilliamsMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Jessica WettsteinInstitute of Medical Sciences, University of Aberdeen, Scotland, UK.
Michelle SimonMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Saumya KumarMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Lee MoirMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Thomas AgnewMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Michelle StewartMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Allison LandmanMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Vassilios N KotiadisDepartment of Cell and Developmental Biology, University College London (UCL), London, UK.
Michael R DuchenDepartment of Cell and Developmental Biology, University College London (UCL), London, UK.
Henning WackerhageInstitute of Medical Sciences, University of Aberdeen, Scotland, UK.
David C RubinszteinDepartment of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, UK.
Steve D M BrownMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Abraham Acevedo-ArozenaMammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
Mary Lyon Centre at MRC Harwell · GBUniversity College London · GBUniversity of Aberdeen · GBHospital Universitario de Canarias · ESUniversity of Cambridge · GBUniversity of York · GB

Funding

Medical Research Council MC_U142684172Medical Research Council MC_UP_1502/1Medical Research Council MC_UP_A390_1106Medical Research Council UKDRI-2002Wellcome TrustWellcome Trust 095317/Z/11/ZWellcome Trust 100140/Z/12/Z
6 · The paper itself

Abstract

Polyglutamine expansions in the huntingtin gene cause Huntington's disease (HD). Huntingtin is ubiquitously expressed, leading to pathological alterations also in peripheral organs. Variations in the length of the polyglutamine tract explain up to 70% of the age-at-onset variance, with the rest of the variance attributed to genetic and environmental modifiers. To identify novel disease modifiers, we performed an unbiased mutagenesis screen on an HD mouse model, identifying a mutation in the skeletal muscle voltage-gated sodium channel (Scn4a, termed 'draggen' mutation) as a novel disease enhancer. Double mutant mice (HD; Scn4aDgn/+) had decreased survival, weight loss and muscle atrophy. Expression patterns show that the main tissue affected is skeletal muscle. Intriguingly, muscles from HD; Scn4aDgn/+ mice showed adaptive changes similar to those found in endurance exercise, including AMPK activation, fibre type switching and upregulation of mitochondrial biogenesis. Therefore, we evaluated the effects of endurance training on HD mice. Crucially, this training regime also led to detrimental effects on HD mice. Overall, these results reveal a novel role for skeletal muscle in modulating systemic HD pathogenesis, suggesting that some forms of physical exercise could be deleterious in neurodegeneration.

Indexed as

AnimalsDisease Models, AnimalEndurance TrainingEnhancer Elements, GeneticHumansHuntingtin ProteinHuntington DiseaseMiceMuscular AtrophyMutationNAV1.4 Voltage-Gated Sodium ChannelNeuronsOrganelle BiogenesisPeptidesPhysical Conditioning, AnimalTrinucleotide Repeat ExpansionHTT protein, humanHuntingtin ProteinNAV1.4 Voltage-Gated Sodium ChannelPeptidespolyglutamineSCN4A protein, humanScn4a protein, mouse

Identifiers

PMID29509900
PMCPMC5932560
OpenAlexW2792975965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.